Pharmacologic Methods for Airway Clearance
Hours: 1.00
Airway mucus plays a critical role in protecting the respiratory tract against toxins and microorganisms. Disease states associated with abnormal mucus production or airway clearance increase the risk of infection and airway obstruction, and mucoactive medications for airway clearance are frequently prescribed. However, there is a lack of evidence-based support for many of these agents. As specialists in caring for patients with cardiopulmonary conditions, respiratory therapists play a vital role in optimizing the use of airway clearance medications.
Airway mucus plays a critical role in protecting the respiratory tract against toxins and microorganisms. Disease states associated with abnormal mucus production or airway clearance increase the risk of infection and airway obstruction, and mucoactive medications for airway clearance are frequently prescribed. However, there is a lack of evidence-based support for many of these agents. As specialists in caring for patients with cardiopulmonary conditions, respiratory therapists play a vital role in optimizing the use of airway clearance medications.
Accreditation Council for Pharmacy Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Type Activity: Knowledge
Target Audience Designation: P
ACPE Universal Activity Number: JA4008266-0000-22-018-H01-P
Florida Board of Respiratory Care
Florida Board of Respiratory Care (CEBroker Provider #50-290)
This module is approved for 1.00 contact hours.
Louisiana State Board of Medical Examiners - Respiratory Therapy
Louisiana State Board of Medical Examiners - Respiratory Therapy (CEBroker Provider #50-290)
Respiratory Therapists will receive 1.00 contact hours for participating in this course.
Mississippi State Department of Health Bureau of Professional Licensure Respiratory Care Practitioners
Mississippi State Department of Health Bureau of Professional Licensure Respiratory Care Practitioners (CEBroker Provider #50-290)
Respiratory Therapists will receive 1.00 contact hours for participating in this course.
American Association for Respiratory Care
This program has been approved as non-traditional Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100 Irving TX 75063.
Approval #: 189904000
This activity is approved for 1.0000 contact hours.
Alabama State Board of Respiratory Therapy
Alabama State Board of Respiratory Therapy (CEBroker Provider #50-290)
This module is approved for 1.00 contact hours.
Oklahoma Board of Medical Licensure and Supervision- Respiratory Therapy
Oklahoma Board of Medical Licensure and Supervision- Respiratory Therapy (CEBroker Provider #50-290)
This module is approved for 1.00 contact hours.
Georgia Composite Medical Board - Respiratory Care Professionals
Recognize disease states associated with abnormal mucus production or clearance.
Choose appropriate pharmacologic agents for airway clearance based on diagnosis and patient factors.
Identify inappropriate medication orders and techniques for promoting evidence-based medication use.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Physiology and Therapeutic Interventions
Physiology of Airway Mucus Secretion and Clearance
Airway Clearance Techniques
Mucoactive Medications
Recommending Medications
Summary
Section 3: Conditions Associated with Mucus Abnormalities
Asthma
Cystic Fibrosis
Non-CF Bronchiectasis
Chronic Obstructive Pulmonary Disease
Inhalation Injury
Neuromuscular Disease and Respiratory Muscle Weakness
Postoperative Atelectasis
Intubation with Mechanical Ventilation
Bronchitis
Cough in the Common Cold
Cough in Palliative Care
Transtracheal Oxygen Therapy
Summary
Section 4: Medications to Enhance Airway Clearance
Expectorants
Thiols and Thiol Derivatives
Inhaled Anticoagulants
Hypertonic Saline
Mannitol
Recombinant Human Dornase Alfa (Pulmozyme®)
Beta-Agonists
Methylxanthines
Glucocorticoids
Macrolide Antibiotics
Anticholinergics
Hydration
Novel Therapies
Summary
Section 5: Interdisciplinary Collaboration
Importance of Interdisciplinary Collaboration
Techniques for Interdisciplinary Collaboration
Protocol-Directed Respiratory Care
Summary
Section 6: Clinical Vignette
Meet Johnathan
Section 7: Conclusion
Course Summary
Course Contributors
References
Gabrielle Ruggiero has a dual major Bachelor of Arts degree in Biochemistry/Molecular Biology and in Psychology, and a Doctor of Pharmacy degree. She works as a pharmacist at a community hospital and its outpatient chemotherapy infusion center. She also enjoys writing and has earned an Essential Skills Certificate from the American Medical Writers Association. Disclosure: Gabrielle Ruggiero, PharmD, BCPS has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.Writer: Kimberly Workman, MA
Ms. Workman is an Instructional Designer at Relias. She has a Master of Arts in Technology and Communication, as well as graduate certificates in Public Health, Epidemiology, and Digital Communications. Ms. Workman has a background in writing and designing online continuing medical education for physicians and other health professionals on multiple educational platforms, including web-based, game-based, and immersive learning environments. She has also used simulation training extensively to connect learning to real-world environments. Disclosure: Kimberly Workman, MA discloses the following potential conflict of interests/commercial interests: Relevant Financial Relationship with Relias LLC as a Salaried Employee All of the relationships listed for this individual have been mitigated.Relevant Non-Financial Relationship with No Entities Exists as a Contributor All of the relationships listed for this individual have been mitigated.
The target audience for this course is: Pharmacists; Respiratory Therapists; in the following settings: Acute Care Facility.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
